Prefilled syringes offer various advantages over conventional vial-and-syringe systems such as improved dosing accuracy, reduced risk of contamination and needle-stick injuries, and elimination of reconstitution steps. They also facilitate self-administration of drugs by patients which is driving the demand for prefilled syringes especially for treatment of chronic diseases. Prefilled syringes are widely used for delivery of vaccines, insulin, and other biologics. The growth of biologics market and rising prevalence of chronic diseases such as diabetes are major factors boosting the demand for prefilled syringes.

The Global Prefilled Syringes Market Size is estimated to be valued at US$ 11.93 Bn in 2024 and is expected to exhibit a CAGR of 4.7% over the forecast period from 2024 to 2030.

Key Takeaways

Key players operating in the prefilled syringes are The Kraft Heinz Company, Starbucks Coffee Company, The J.M. Smucker Company, Luigi Lavazza SPA, Nestle SA, The Coca-Cola Company, JAB Holding Company, Tata Global Beverages, Tchibo GmbH, and Strauss Group Ltd. These players are focusing on new product launches, expansion of regional presence and mergers and acquisitions to gain market share.

The demand for prefilled syringes is growing significantly mainly due to rising incidence of chronic diseases, technological advancements in prefilled syringe systems, and increasing preference for self-administration of drugs. Biologics occupy nearly one-third of the pharmaceutical pipeline, and the revenues are projected to grow exponentially creating huge demand for prefilled syringes.

Geographically, North America dominates the global prefilled syringes market due to increasing demand for self-injectable drugs and supportive regulatory framework for approval of novel drug delivery systems. However, Asia Pacific is expected to exhibit the highest growth over the forecast period owing to improving healthcare infrastructure and increasing penetration of biologics in disease markets such as diabetes in populous countries such as India and China.

Market drivers

Increasing volume of medicines administered through injection drives the prefilled syringes market. Biologics have revolutionized the treatment of chronic diseases but require syringe delivery. With rising disease burden and growing access to biologics globally the demand for prefilled syringes will scale up in the future. The COVID-19 pandemic has also highlighted the importance of syringe based delivery of vaccines and therapeutics. Cost-effective and user-friendly prefilled syringes are indispensable for mass immunization programs against infectious diseases.

The current geopolitical situations worldwide are impacting the growth of the prefilled syringes market. With growing political tensions and conflicts between nations, cross-border trades and collaborations among pharmaceutical companies located in different regions have become challenging. This can hinder the global supply chains of prefilled syringes and affect their timely availability. The ongoing Russia-Ukraine war has disrupted the supply of glass barrels and other raw materials required for manufacturing prefilled syringes. This has compelled European manufacturers to rely on alternative regional suppliers and explore new trade agreements, increasing overall costs. Similarly, political instability and stringent import-export regulations in the Middle East and African nations can restrain market expansion in those areas. Companies must diversify their supplier networks across multiple regions and countries to mitigate single-point supply risks due to geopolitical issues. They also need to invest in developing efficient cross-border logistic capabilities and establishing local manufacturing facilities in growing markets through strategic partnerships. This will help make their supply chains more self-reliant and resilient to withstand future geopolitical challenges.

Europe currently dominates the global prefilled syringes market in terms of value, accounting for over 30% revenue share. This is attributed to factors like the large presence of pharmaceutical manufacturers, favorable healthcare reforms, and rising prevalence of chronic diseases in the region prompting increased self-administrations of drugs. However, Asia Pacific is emerging as the fastest growing regional market due to expanding healthcare infrastructure, growing patient awareness, and increasingGeneric penetrations in countries like India, China, and Indonesia. Additionally, improving regulatory frameworks and investment-friendly policies are encouraging pharmaceutical firms to set up manufacturing plants in Asia Pacific, augmenting local production of prefilled syringes.

Get More Insights on This Topic: https://www.newsanalyticspro.com/prefilled-syringes-market-size-share-and-growth-forecast-2024-2030/